:

Siddhartha Yadav1, Fergus J Couch2, Susan M Domchek3

  • 1Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA yadav.siddhartha@mayo.edu couch.fergus@mayo.edu susan.domchek@pennmedicine.upenn.edu.

概括

对于遗传性乳腺癌和卵巢癌的生殖基因测试已经取得了进展,识别了超出BRCA1/2.2的风险. 风险评估现在考虑了高风险和一般人群中的基因,家族史和变异类型.